| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2020 | Aug 27, 2020 | Demaree John Chief Commercial Officer | Buy | Karyopharm Therapeutics Inc. | KPTI | $14.54 | $109,013 | +50.00% |
| Dec 10, 2018 | Dec 11, 2018 | Demaree John Chief Commercial Officer | Buy | G1 Therapeutics, Inc. | GTHX | $33.15 | $33,151 | +16.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.